Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Japan (N.T., Y.M., Y.I., Y.S.-W., T.A., K.H., M.I.).
Department of Cardiovascular Medicine, The University of Tokyo, Japan (T.M., E.A., I.K.).
Circ Genom Precis Med. 2018 Oct;11(10):e002296. doi: 10.1161/CIRCGEN.118.002296.
Takayasu arteritis (TAK) is an autoimmune systemic arteritis of unknown pathogenesis. Genome-wide association studies revealed that single-nucleotide polymorphisms in the MLX gene encoding the MLX (Max-like protein X) transcription factor are significantly associated with TAK in Japanese patients. MLX single-nucleotide polymorphism rs665268 is a missense mutation causing the Q139R substitution in the DNA-binding site of MLX.
To elucidate the hypothesis that the single-nucleotide polymorphism of the MLX gene plays a critical role in the development of TAK, we conducted clinical and laboratory analyses.
We show that rs665268 significantly correlated with the severity of TAK, including the number of arterial lesions and morbidity of aortic regurgitation; the latter may be attributed to the fact that MLX mRNA expression was mostly detected in the aortic valve. Furthermore, the Q139R mutation caused structural changes in MLX, which resulted in enhanced formation of a heterodimer with MondoA, upregulation of TXNIP (thioredoxin-interacting protein) expression, and increase in the activity of the NLRP3 (NACHT, LRR, and PYD domains-containing protein 3) inflammasome and cellular oxidative stress. Furthermore, autophagy, which negatively regulates inflammasome activation, was suppressed by the Q139R mutation in MLX. The MLX-Q139R mutant significantly induced macrophage proliferation and macrophage-endothelium interaction, which was abolished by the treatment with SBI-477, an inhibitor of MondoA nuclear translocation. Our findings suggest that the Q139R substitution in MLX plays a crucial role in the pathogenesis of TAK.
MLX-Q139R mutation plays a crucial role in the pathogenesis of TAK through promoting inflammasome formation.
Takayasu 动脉炎(TAK)是一种病因不明的自身免疫性系统性动脉炎。全基因组关联研究表明,编码 MLX(Max-like 蛋白 X)转录因子的 MLX 基因中的单核苷酸多态性与日本患者的 TAK 显著相关。MLX 单核苷酸多态性 rs665268 是一种错义突变,导致 MLX DNA 结合位点的 Q139R 取代。
为了阐明 MLX 基因单核苷酸多态性在 TAK 发病机制中起关键作用的假说,我们进行了临床和实验室分析。
我们表明 rs665268 与 TAK 的严重程度显著相关,包括动脉病变的数量和主动脉瓣反流的发病率;后者可能归因于 MLX mRNA 表达主要在主动脉瓣中检测到的事实。此外,Q139R 突变导致 MLX 结构发生变化,导致与 MondoA 形成异二聚体增强,TXNIP(硫氧还蛋白相互作用蛋白)表达上调,NLRP3(NACHT、LRR 和 PYD 结构域包含蛋白 3)炎症小体活性和细胞氧化应激增加。此外,自噬通过负调控炎症小体激活而被 MLX 的 Q139R 突变抑制。MLX-Q139R 突变体显著诱导巨噬细胞增殖和巨噬细胞-内皮相互作用,用 MondoA 核易位抑制剂 SBI-477 处理可消除这种作用。我们的研究结果表明,MLX 中的 Q139R 取代在 TAK 的发病机制中起关键作用。
MLX-Q139R 突变通过促进炎症小体形成在 TAK 的发病机制中起关键作用。